These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3144646)

  • 21. EDTA chelation therapy for cardiovascular disease: a systematic review.
    Seely DM; Wu P; Mills EJ
    BMC Cardiovasc Disord; 2005 Nov; 5():32. PubMed ID: 16262904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA.
    Guldager B; Jørgensen PJ; Grandjean P
    Clin Chem; 1996 Dec; 42(12):1938-42. PubMed ID: 8969629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chelation therapy for coronary heart disease: An overview of all clinical investigations.
    Ernst E
    Am Heart J; 2000 Jul; 140(1):139-41. PubMed ID: 10874275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis.
    Sloth-Nielsen J; Guldager B; Mouritzen C; Lund EB; Egeblad M; Nørregaard O; Jørgensen SJ; Jelnes R
    Am J Surg; 1991 Aug; 162(2):122-5. PubMed ID: 1907432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chelation therapy for ischemic heart disease: a randomized controlled trial.
    Knudtson ML; Wyse DG; Galbraith PD; Brant R; Hildebrand K; Paterson D; Richardson D; Burkart C; Burgess E;
    JAMA; 2002 Jan 23-30; 287(4):481-6. PubMed ID: 11798370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Follow-up examinations of patients treated with EDTA for scleroderma].
    Langhof H
    Dermatol Wochenschr; 1965 Jul; 151(30):862-4. PubMed ID: 4954170
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiology Patient Page. Chelation therapy: a new look at an old treatment for heart disease, particularly in diabetics.
    Lamas GA
    Circulation; 2015 May; 131(21):e505-6. PubMed ID: 26015468
    [No Abstract]   [Full Text] [Related]  

  • 28. So much writing, so little science: a review of 37 years of literature on edetate sodium chelation therapy.
    Grier MT; Meyers DG
    Ann Pharmacother; 1993 Dec; 27(12):1504-9. PubMed ID: 8305786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An objective evaluation of the treatment of systemic scleroderma with disodium EDTA, pyridoxine and reserpine.
    Fuleihan FJ; Kurban AK; Abboud RT; Beidas-Jubran N; Farah FS
    Br J Dermatol; 1968 Mar; 80(3):184-9. PubMed ID: 4967134
    [No Abstract]   [Full Text] [Related]  

  • 30. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease.
    Wiseman LR; Fitton A; Buckley MM
    Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
    Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute prooxidant effects of vitamin C in EDTA chelation therapy and long-term antioxidant benefits of therapy.
    Hininger I; Waters R; Osman M; Garrel C; Fernholz K; Roussel AM; Anderson RA
    Free Radic Biol Med; 2005 Jun; 38(12):1565-70. PubMed ID: 15917185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of EDTA chelation therapy.
    Jonas WB
    Circulation; 1995 Sep; 92(5):1352. PubMed ID: 7648688
    [No Abstract]   [Full Text] [Related]  

  • 34. Chelation therapy after the trial to assess chelation therapy: results of a unique trial.
    Avila MD; Escolar E; Lamas GA
    Curr Opin Cardiol; 2014 Sep; 29(5):481-8. PubMed ID: 25023079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous magnesium sulfate with and without EDTA as a magnesium load test-is magnesium deficiency widespread?
    Waters RS; Fernholz K; Bryden NA; Anderson RA
    Biol Trace Elem Res; 2008 Sep; 124(3):243-50. PubMed ID: 18665335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of systemic sclerosis with disodium edta, pyridoxine and reserpine.
    Birk RE; Rupe CE
    Henry Ford Hosp Med J; 1966 Jun; 14(2):109-18. PubMed ID: 4957307
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of ethylenediaminetetraacetic acid (EDTA) and tetrahydroxyquinone on sclerodermatous skin. Histologic and chemical studies.
    Keech MK; McCann DS; Boyle AJ; Pinkus H
    J Invest Dermatol; 1966 Sep; 47(3):235-46. PubMed ID: 4958819
    [No Abstract]   [Full Text] [Related]  

  • 38. [Is chelation therapy in coronary heart disease useful?].
    Schnabel P; Erdmann E
    Dtsch Med Wochenschr; 2002 Aug; 127(33):1715. PubMed ID: 12183807
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acetylsalicylic acid therapy in vascular diseases].
    Ranke C; Creutzig A; Alexander K
    Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1158-61. PubMed ID: 3292193
    [No Abstract]   [Full Text] [Related]  

  • 40. Chelation therapy in cardiovascular disease: an update.
    Sultan S; Murarka S; Jahangir A; Mookadam F; Tajik AJ; Jahangir A
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):843-854. PubMed ID: 28597699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.